OVCAR-8-Luc Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | OVCAR-8-Luc cells are a bioluminescent derivative of the human ovarian adenocarcinoma cell line OVCAR-8, which was originally established from an adult patient with advanced-stage disease. These cells have been genetically engineered to stably express luciferase, an enzyme that catalyzes light emission in the presence of its substrate, enabling highly sensitive, non-invasive monitoring of cellular activity. The parental OVCAR-8 line is characterized by aggressive growth, genomic instability, and features representative of high-grade serous ovarian cancer, making it a widely used model for studying ovarian tumor biology. The incorporation of luciferase allows OVCAR-8-Luc cells to be used in longitudinal in vivo imaging applications, particularly in xenograft and orthotopic tumor models, where tumor burden and metastatic dissemination can be quantitatively tracked over time using bioluminescence imaging. These cells retain key molecular and phenotypic traits of the parental line, including alterations in pathways relevant to ovarian cancer progression such as p53 dysfunction and dysregulated cell cycle control. Consequently, OVCAR-8-Luc cells are well suited for evaluating therapeutic efficacy, tumor growth kinetics, and metastatic behavior, as well as for studying tumor microenvironment interactions in preclinical research. |
|---|---|
| 生物體 | Human |
| 組織 | Ovary |
| 疾病 | Adenocarcinoma |
| 轉移部位 | Primary tumor site (ovary) |
| 應用 | Ovarian cancer research; bioluminescence imaging in xenograft/orthotopic models; in vivo tumor burden tracking; drug efficacy and pharmacodynamics; PARP inhibitor and platinum sensitivity studies; peritoneal metastasis modeling; ovarian cancer immunotherapy evaluation |
| 同義詞 | OVCAR 8, NIH:OVCAR-8, OVCAR8, Ovcar8, OVCAR.8, OVCA8, OVCAR-8/EGFP_LC3 |
特徵
| 年齡 | 64 years |
|---|---|
| 性別 | Female |
| 族裔 | Caucasian |
| 形態學 | Epithelial-like |
| 細胞類型 | Epithelial cells |
| 生長特性 | Adherent |
監管數據
| 引用 | OVCAR-8-Luc (Cytion catalog number 305697) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_2169 |
| 轉基因狀態 | GMO-S1: This human ovarian carcinoma cell line (OVCAR-8-Luc) contains a lentiviral firefly-Luc reporter construct, enabling bioluminescent tracking. The insert is stably integrated. This classification applies only within Germany and may differ elsewhere. |
生物分子資料
| 蛋白質表達 | Luc |
|---|
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 播種密度 | 1-3 x 104 cells/mL |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305697-090326 | 分析證明書 | 13. Apr. 2026 | 305697 |